sue bewes

#PublicHealth #Immunisation #Oncology #CervicalCancerEradication Dr Neil Stone's highlights on the human papillomavirus (HPV) vaccine reflect a milestone in preventive medicine: Gardasil has turned cervical cancer into a preventable, potentially eradicable disease. From an epidemiological and global health perspective, the clinical impact of national HPV immunisation programmes shows significant outcomes: Population-Level Efficacy: Real-world observational data from national registries—including Public Health Scotland, Sweden's Karolinska Institutet, and Australia's national screening framework—demonstrate up to an 87–90% reduction in cervical cancer incidence among cohorts vaccinated at ages 12–13. Herd Protection and Elimination Targets: High uptake across adolescent populations has drastically reduced the prevalence of oncogenic HPV strains (particularly HPV 16 and 18). Australia remains on track to become the first nation to effectively eliminate cervical cancer as a public health concern by 2035. Policy and Misinformation Friction: Despite overwhelming scientific consensus and WHO backing, public confidence in routine immunisation faces headwind from anti-vaccine rhetoric and political figures who challenge established safety and efficacy data.